A profit warning from Craneware (AIM:CRW) dominated the technology small-cap space on Friday, sending the healthcare software group's shares down nearly 25% after it flagged that both revenue and profit would fall short of market expectations for FY26. Elsewhere, MedPal AI (AIM:MPAL) raised £5m to pursue a care-home software acquisition and position itself ahead of the UK launch of oral Wegovy, while contract wins and legal progress rounded out a busy session.
Craneware issues profit warning as FY26 growth disappoints
Craneware (AIM:CRW) told the market that revenue and profit for the year ending June 2026 would come in below analyst expectations, triggering a sharp sell-off that left the shares at 1098.0p, down 24.9%. The US-focused hospital financial software specialist cited a slower-than-expected pace of new business conversion as the primary drag on the year's performance.
Chief executive Keith Neilson acknowledged the shortfall directly, saying the group was "disappointed not to have delivered the growth that we expected in FY26," while maintaining that "the long-term opportunity remains intact." The warning will nonetheless reset near-term expectations materially for a stock that had commanded a premium rating on its recurring-revenue model.
MedPal AI raises £5m for care-home platform and oral Wegovy push
MedPal AI (AIM:MPAL) raised £5m to fund two parallel initiatives: completing a closed-loop medication management platform targeting the care-home sector, and capitalising on the UK launch of oral Wegovy on 6 July. The AIM-traded digital pharmacy group intends to use the proceeds to complete an acquisition of a care-home software firm that would underpin the platform, creating an integrated dispensing and monitoring solution for residential care operators.
The fundraise also positions MedPal to launch a dedicated oral Wegovy clinic, entering the weight-loss drug market at the point of the new formulation's domestic debut. The shares eased 8.75% to 3.65p on the day, a reaction consistent with placing-related dilution rather than any adverse news on the underlying strategy.
Crimson Tide renews Cadent contract on improved terms
Crimson Tide (AIM:TIDE) secured a renewal of its contract with gas distribution network Cadent, with the new agreement struck at a higher rate than the previous term. The deal extends the deployment of the company's mpro5 workflow platform across Cadent's field operations, reinforcing the software's position as embedded infrastructure within one of the UK's largest utility networks.
Chief executive Jon Clarke described the renewal as evidence of "the mission-critical role that mpro5 plays in supporting the operations of large, complex enterprises." The shares dipped 2.7% to 90.0p, a modest move that appeared to reflect broader market tone rather than any negative read on the contract terms.
Quantum Blockchain wins court ruling to restart Italian property auction
Quantum Blockchain Technologies (AIM:QBT) secured a court ruling allowing an Italian property auction to resume as part of its ongoing Sipiem asset recovery process. The ruling clears a procedural obstacle that had stalled the auction, which forms a key mechanism through which the company aims to recover sums awarded to its CL2017 creditor vehicle.
Chief executive Francesco Gardin said the decision "removes a significant procedural obstacle and represents another important step in our strategy to recover the sums awarded to CL2017." The shares were down 2.72% at 0.3502p, with the legal progress yet to translate into a material re-rating given the recovery process remains at an early stage.
Defence Holdings secures maiden Ministry of Defence contract
Defence Holdings announced the award of its first revenue-generating contract with the Ministry of Defence, a milestone the company described as defining for its development. The contract marks the transition from a pre-revenue footing to active delivery within the UK defence procurement ecosystem, providing both commercial validation and a reference point for future tender activity.
Chief executive Andrew Roughan called the win "a defining milestone for Defence Holdings," signalling confidence that the initial award opens a pathway to further MoD engagement. No stock price data was available for the company at the time of publication.
